Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)
India
· Delayed Price · Currency is INR 367.90
+13.40 (3.78%)
Jun 6, 2025, 3:29 PM IST
Dr. Agarwal's Health Care Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Net Income | 834.6 | 830.61 | 940.97 | 376.94 | -554.78 |
| Depreciation & Amortization | 2,307 | 1,699 | 1,235 | 871.07 | 871.96 |
| Other Amortization | 15.5 | 4.85 | 48.1 | 68.5 | 75.49 |
| Loss (Gain) From Sale of Assets | 4.3 | -1.87 | -0.4 | 2.36 | -25.89 |
| Asset Writedown & Restructuring Costs | 30.2 | 0.3 | - | 37.03 | 8.08 |
| Loss (Gain) From Sale of Investments | -171.3 | -246.69 | -46.62 | - | - |
| Loss (Gain) on Equity Investments | - | - | - | - | 7.01 |
| Stock-Based Compensation | 83.8 | 50.6 | 18.26 | - | - |
| Provision & Write-off of Bad Debts | 148.5 | 112.24 | 117.54 | 111 | 123 |
| Other Operating Activities | 1,294 | 964.79 | 143.4 | 326.49 | 389.01 |
| Change in Accounts Receivable | -436.4 | -292.54 | -313.69 | -211.05 | -55.11 |
| Change in Inventory | -264.8 | -152.83 | -24.92 | -46.89 | 55.7 |
| Change in Accounts Payable | 266 | 360.74 | 128.93 | 168.57 | 106.24 |
| Change in Other Net Operating Assets | -508.1 | 130.57 | 84.63 | -60.74 | -9.11 |
| Operating Cash Flow | 3,603 | 3,460 | 2,331 | 1,643 | 991.59 |
| Operating Cash Flow Growth | 4.15% | 48.41% | 41.85% | 65.72% | - |
| Capital Expenditures | -3,087 | -2,309 | -1,566 | -702.39 | -1,266 |
| Sale of Property, Plant & Equipment | 5.3 | 42.49 | 5.03 | 8.11 | 933.01 |
| Cash Acquisitions | -5,158 | -2,867 | -3,208 | -797.06 | - |
| Sale (Purchase) of Intangibles | -122.5 | -14.34 | -12.28 | -3.49 | - |
| Investment in Securities | 2,239 | -4,122 | -289.98 | - | - |
| Other Investing Activities | -1,381 | 130.6 | -20.12 | -58.68 | -33.17 |
| Investing Cash Flow | -7,503 | -9,139 | -5,091 | -1,554 | -365.69 |
| Short-Term Debt Issued | - | - | - | - | 125.13 |
| Long-Term Debt Issued | 615.2 | 2,452 | 1,731 | 1,110 | 243.22 |
| Total Debt Issued | 615.2 | 2,452 | 1,731 | 1,110 | 368.35 |
| Short-Term Debt Repaid | - | - | - | - | -142.33 |
| Long-Term Debt Repaid | -3,015 | -2,968 | -1,409 | -694.66 | -405.99 |
| Total Debt Repaid | -3,015 | -2,968 | -1,409 | -694.66 | -548.33 |
| Net Debt Issued (Repaid) | -2,400 | -515.59 | 321.45 | 415.4 | -179.97 |
| Issuance of Common Stock | 2,799 | 6,400 | 3,009 | - | - |
| Common Dividends Paid | -7.9 | -7.73 | -4.28 | -0.07 | - |
| Other Financing Activities | -368.8 | -350.89 | -292.74 | -209.25 | -191.1 |
| Financing Cash Flow | 3,819 | 5,527 | 3,033 | 354.33 | -371.07 |
| Foreign Exchange Rate Adjustments | - | - | - | - | -89.27 |
| Miscellaneous Cash Flow Adjustments | 0.1 | - | - | - | - |
| Net Cash Flow | -81.4 | -152.32 | 273.6 | 444.1 | 165.55 |
| Free Cash Flow | 516.8 | 1,151 | 765.33 | 940.89 | -273.95 |
| Free Cash Flow Growth | -55.09% | 50.36% | -18.66% | - | - |
| Free Cash Flow Margin | 3.02% | 8.64% | 7.52% | 13.52% | -5.81% |
| Free Cash Flow Per Share | 1.72 | 4.34 | 3.25 | 4.57 | -1.33 |
| Cash Interest Paid | 322.4 | 321.5 | 292.74 | 207.67 | 190.68 |
| Cash Income Tax Paid | 366 | 320.94 | 353.83 | 155.96 | 74.95 |
| Levered Free Cash Flow | -475 | 395.9 | 584.17 | 533.38 | - |
| Unlevered Free Cash Flow | 204.94 | 993.54 | 1,034 | 817.12 | - |
| Change in Net Working Capital | 403.01 | -363.1 | -410.45 | -54.11 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.